Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Szkandera Joanna |

Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen

Joch, S; Smolle, MA; Kashofer, K; Thüringer, A; Szkandera, J; Benesch, M; El-Heliebi, A; Liegl-Atzwanger, B; Leithner, A; Seidel, MG ctDNA monitoring of translocation-associated sarcomas.
37th Annual Meeting of the European Musculo-Skeletal Oncology Society (EMSOS); APRIL 28-30, 2025; Padova, ITALY. 2025. [Poster]

 

Leithner, A; Scheipl, S; Smolle, MA; Igrec, J; Szkandera, J; Godschachner, TM; Tiesenhausen, K; Liegl-Atzwanger, B Ein Unglück kommt selten allein.
Weichteilsarkom Kasuistiken; APR 4, 2025; Salzburg, AUSTRIA. 2025. [Oral Communication]

 

Smolle, MA; Golja, B; Liegl-Atzwanger, B; Szkandera, J; Scheipl, S; Leithner, A Frequency in grading changes of soft tissue sarcomas upon local recurrence or distant metastasis.
Abstract Book of the 37th Annual Meeting of the European Musculoskeletal Oncology Society (EMSOS). 2025; -37th Annual Meeting of the European Musculoskeletal Oncology Society (EMSOS); APR 28-30, 2025; Padova, ITALY. [Oral Communication]

 

Smolle, MA; Wenzl, FA; Szkandera, J; Scheipl, S; Liegl-Atzwanger, B; Igrec, J; Leithner, A Changes in age-adjusted incidence and survival of patients with bone and soft tissue sarcoma over 4 decades across Austria.
Abstract Book of the 37th Annual Meeting of the European Musculoskeletal Oncology Society (EMSOS). 2025; -37th Annual Meeting of the European Musculoskeletal Oncology Society (EMSOS); APR 28-30, 2025; Padova, ITALY. [Poster]

 

Smolle, MA; Wenzl, FA; Szkandera, J; Scheipl, S; Liegl-Atzwanger, B; Igrec, J; Leithner, A Knochen- und Weichteilsarkome in Österreich. Trends in Inzidenz- und Überlebensraten.
Abstractband des Österreichischen Kongresses für Orthopädie und Traumatologie (ÖKOuT). 2025; -Österreichischer Kongress für Orthopädie und Traumatologie (ÖKOuT); MAY 7-9, 2025; Vienna, AUSTRIA. [Oral Communication]

 

Smolle, MA; Wenzl, FA; Szkandera, J; Scheipl, S; Liegl-Atzwanger, B; Igrec, J; Leithner, A Bone and soft tissue sarcoma incidences and survival rates over 4 decades across Austria.
26th International MUTARS Workshop; MAR 21-23, 2025; Palma de Mallorca, SPAIN. 2025. [Oral Communication]

 

Szkandera, J Update der systemischen Therapie bei fortgeschrittenen retroperitonealen Sarkomen
Sarkomkonferenz 2025; MAR 13-15, 2025; München, DEUTSCHLAND. 2025. [Oral Communication]

 

Szkandera, J Tracing the Evolution of Drug Therapies for Soft Tissue Sarcoma: A Journey Through Medical Failures and Breakthroughs
EMSOS; APR 28-30, 2025; Padua, Italy. 2025. [Keynote lecture]

 

Szkandera, J Systemische Behandlung ultraseltener Sarkome
ÖGHO; APR 24-26, 2025; Salzburg, AUSTRIA. 2025. [Oral Communication]

 

Szkandera, J Standards and New Developments in the Treatment of Bone Sarcoma
EMSOS; APR 28-30, 2025; Padua, Italy. 2025. [Oral Communication]

 

Andreou, D; Liegl-Atzwanger, B; Szkandera; J Interaktive Fallvorstellungen zur interdisziplinären Behandlung von Knochen- und Weichgewebesarkomen
Sarkomkonferenz 2024; MAR 7-9, 2024; Essen, Deutschland. 2024. [Oral Communication]

 

Dimosthenis, A; Rothermundt, C; Haas, R; Jakob, J; Kunz, W; Leithner, A; Liegl-Atzwanger, B; Miah, A; Szkandera, J; Van Houdt, W; Wardelmann, E; Hofer S Controversies In The Management Of Patients With Soft Tissue Sarcoma: Results And Recommendations From The First Conference On State Of Science In Sarcoma (CSSS)
EFORT Annual Congress; May 22-24, 2024; Hamburg, GERMANY. 2024. [Oral Communication]

 

Leithner, A; Scheipl, S; Brcic, I; Igrec, J; Szkandera, J; Liegl-Atzwanger, B D_TGCT: ein benigner Tumor?
Weichteilsarkom Kasuistiken: Interdisziplinäres Sarkomtreffen.; APR 19, 2024; Salzburg, AUSTRIA. 2024. [Oral Communication]

 

Leithner, A; Szkandera, J The status of data collection in Europe.
22nd International Society of Limb Salvage General Meeting; OCT 8-11, 2024; Brisbane, AUSTRALIA. 2024. [Oral Communication]

 

Smolle, MA; Szkandera, J; Scheurer, FA; Seeber, A; Hasenschandtner, S; Liegl-Atzwanger, B; Weiss, L; Winder, T; Müller, DA; Leithner, A Outcome analysis in soft tissue sarcoma. Parameters associated with local recurrence, distant metastasis, and overall survival in 746 STS patients from a multicentre, multinational registry-based study.
Abstract Book of the 36th Annual Meeting of the European Musculo-Skeletal Oncology Society. 2024; -36th Annual Meeting of the European Musculo-Skeletal Oncology Society (EMSOS); JUN 12-14, 2024; Szczecin, POLAND. [Oral Communication]

 

Smolle, MA; Szkandera, J; Scheurer, FA; Seeber, A; Hasenschwandtner, S; Liegl-Atzwanger, B; Weiss, L; Winder, T; Müller, DA; Leithner, A Outcome prediction in soft tissue sarcomas. Parameters associated with local recurrence, distant metastasis, and overall survival in 746 sts patients from a multicentre, multinational study.
Jahreskongress swiss orthopaedics 2024; JUN 26-28, 2024; Lausanne, SWITZERLAND. 2024. [Oral Communication]

 

Szkandera, J Immuntherapie bei Sarkomen?
DGHO; OKT 11-14, 2024; Basel, SCHWEIZ. 2024. [Oral Communication]

 

Szkandera, J Clinical impact of the registry results
EMSOS; JUNE 12-14, 2024; Szczetin, POLAND. 2024. [Oral Communication]

 

Szkandera, J Update on current studies in STS
EMSOS; JUNE 12-14, 2024; Szczetin, POLAND. 2024. [Keynote lecture]

 

Szkandera, J Immuntherapie bei Sarkomen? Alle, keiner oder wer jetzt?
Sarkomkonferenz 2024; MAR 7-9, 2024; Essen, DEUTSCHLAND. 2024. [Oral Communication]

 

Szkandera, J Mini oral session sarcoma: Invited Discussion on LBA80, 1720MO and 1721MO
ESMO Congress 2024; SEPT 13-17, 2024; Barcelona, Spain. 2024. [Oral Communication]

 

Szkandera, J The EURACAN Sarcoma Registry - an European Approach
MSTS Annual Meeting; SEPT 11-13, 2024; Chicago, United States. 2024. [Oral Communication]

 

Szkandera, J First insights from a rare cancer registry
Time To Harvest: Blueberry End Event; AUG 31, 2024; Utrecht. 2024. [Onlinepräsentation]

 

Szkandera, J Invited Discussant abstracts 40O, 146O and 51O
ESMO sarcoma and rare cancers; MAR 14-16, 2024; Lugano,, Schweiz. 2024. [Oral Communication]

 

Szkandera, J Die metastasierte GIST-Erkrankung
3. TriNationales GIST-Patienten-Forum; OCT 25-26, 2024; Berlin, GERMANY. 2024. [Science to Public]

 

Valentini, M; Szkandera, J; Smolle, MA; Scheipl, S; Leithner, A; Andreou, D Artificial Intelligence Bot ChatGPT: Is It A Trustworthy And Reliable Source Of Information For Sarcoma Patients?
25th EFORT Annual Congress Hamburg 2024 Scientific Programme. 2024; -EFORT Congress 2024; MAY 22-24, 2024; Hamburg, GERMANY. [Oral Communication]

 

Andreou, D; Rothermund, C; Gelderblom, H; Haas, R; Kunz, WG; Leithner, A; Lindner, LH; Liegl-Atzwanger, B; Szkandera, J; Hofer, S Controversies in the management of patients with soft tissue sarcoma: the top recommendations of the Conference on State of Science in Sarcoma (CSSS) 2022.
Abstract book of the 35th Annual Meetin European Musculo-Sceletal Oncology Society. 2023; 51--EMSOS 2023; May 10-12, 2023; Brüssel, BELGIEN. [Oral Communication]

 

Hofer, S; Andreou, D; Gelderblom, H; Haas, R; Kunz, W; Leithner, A; Szkandera, J; Reichardt, P; Judson, I; Jones, R; Lindner, L; Desar, I; Liegl-Atzwanger, B; van der Graaf, W; Jakob, J; Miah, A; Rutkowski, P; Wardelmann, E; Rothermundt, C Controversies in the management of patients with soft tissue sarcoma: the top recommendations of the Conference on State of Science in Sarcoma (CSSS)
ONCOL RES TREAT. 2023; 46: 156-156.
Web of Science

 

Leithner, A; Seidel, MG; Moser, T; Thueringer, A; Liegl-Atzwanger, B; Szkandera, J; Benesch, M; El-Heliebi, A; Heitzer, E; Kashofer, K Introducting liquid biopsy for paediatric patients into the clinical routine
Proceedings of the ESMO Sarcoma and Rare Cancers Congress 2023. 2023; -ESMO Sarcoma and Rare Cancers Congress; MAR 20-22, 2023; Lugano, SWITZERLAND. [Poster]

 

Leithner, A; Smolle, MA; Brcic, I; Szkandera, J; Bergovec, M; Liegl-Atzwanger, B Weichteilsarkom: Was kann da noch schief gehen?
Weichteilsarkom Kasuistiken: interdisziplinäres Sarkomtreffen; APE 14, 2023; Salzburg, AUSTRIA. 2023. [Oral Communication]

 

Neufeldt, D; Jonas, K; Rinner, B; Szkandera, J; Rank, A; Jahn, S; Liegl-Atzwanger, B; Trepel, M; Pichler, M Long non-coding RNA PANTR1 is associated with poor prognosis in sarcoma
ONCOL RES TREAT. Abstracts. 2023; 46(S5):156-156.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; OCT 13-16, 2023; Hamburg, GERMANY. [Oral Communication]
Web of Science

 

Seidel, M; Leithner, A; Kashofer, K; Moser, T; Thüringer, A; Liegl-Atzwanger, B; Szkandera, J; Benesch, M; El-Heliebi, A; Heitzer, E Liquid Biopsy In Paediatric Ewing Sarcoma Patients: A Pilot Study.
Abstracts of the 24th EFORT Annual Congress:#2198. 2023; -24th EFORT Annual Congress; MAY 24-26, 2023; Vienna, AUSTRIA. [Oral Communication]

 

Smolle, MA; Andreou, D; Scheipl, S; Bergovec, M; Leithner, A; Szkandera, J Untersuchung des Effekts einer neoadjuvanten oder adjuvanten Strahlentherapie auf die Prognose von 1200 Weichteilsarkom-PatientInnen
2. Österreichischer Kongress für Orthopädie & Traumatologie; MAY 4-6, 2023; Vienna, AUSTRIA. 2023. [Oral Communication]

 

Smolle, MA; Helmberg, W; Szkandera, J; Liegl-Atzwanger, B; Leithner, A; Pichler, M Einfluss der perioperativen Erythrozytenkonzentrat-Gabe auf die Prognose von WeichteilsarkompatientInnen.
2. Österreichischer Kongress für Orthopädie & Traumatologie; MAY 4-6, 2023; Vienna, AUSTRIA. 2023. [Oral Communication]

 

Smolle, MA; Herbsthofer, L; Prietl, B; El-Heliebi, A; Pichler, M; Tomberger, M; Feichtinger, J; Baumgartner, C; Leithner, A; Liegl-Atzwanger, B; Szkandera, J Impact Of Tumour-Infiltrating Immune Cells On Oncological Outcome (Local Recurrence, Distant Metastasis, Overall Survival) In Soft Tissue Sarcoma Patients.
Online Abstract Book of the 24th EFORT Congress. 2023; -24th EFORT Congress; MAY 24-26, 2023; Vienna, AUSTRIA. [Oral Communication]

 

Smolle, MA; Musser, E; Bergovec, M; Wibmer, CL; Leitner, L; Scheipl, S; Sorensen, MS; Friesenbichler, J; Petersen, MM; Brcic, I; Szkandera, J; Leithner, A Validation Of The 2013-SPRING Model For Survival Prediction In Surgically Treated Patients With Long-Bone Metastases Using An External Cohort.
Online Abstract Book of the 24th EFORT Congress. 2023; -24th EFORT Congress; MAY 24-26, 2023; Vienna, AUSTRIA. [Oral Communication]

 

Szkandera, J Systemische Therapieoptionen bei seltenen Subtypen
DGHO; OKT 13-16, 2023; Hamburg, DEUTSCHLAND. 2023. [Oral Communication]

 

Szkandera, J Praxis-Check „Organisation von Sarkom-Zentren“
Sarkomkonferenz 2023; MARCH 16-18, 2023; Berlin, Germany. 2023. [Oral Communication]

 

Valentini, M; Szkandera, J; Scheipl, S; Smolle, MA; Leithner, A; Andreou, D Artificial Intelligence Bot ChatGPT: is it a trustworthy and reliable source of information for patients?.
Abstract Book of the 35th Annual Meeting European Musculo-Skeletal Oncology Society. 2023; 40--EMSOS 2023; MAY 10-12, 2023; Brüssel, BELGIEN. [Oral Communication]

 

Jernej, L; Smolle, M; Lohberger, B ; Leithner, A; Bergovec, M; Liegl-Atzwanger, B; Szkandera, J; Brcic, I Erfolg und Sicherheit der Denosumab-Therapie bei Riesenzelltumoren des Knochens.
Abstract Book 21/22. 2022; -1. Österreichischer Kongress für Orthopädie und Traumatologie; 12-14.05.2022; Graz. [Poster]

 

Scheipl, S; Brcic, I; Moser, T; Fischerauer, S; Riedl, J; Bergovec, M; Smolle, M; Posch, F; Gerger, A; Pichler, M; Stöger, H; Leithner, A; Heitzer, E; Liegl, B; Szkandera, J Die molekularpathologische Testung von Weichteilsarkomen mittels FoundationOne® Heme bestätigt potentielle therapeutische Targets: Ergebnisse einer monozentrischen Analyse
Abstractband 1. Österreichischer Kongress für Orthopädie & Traumatologie. 2022; -1. Österreichischer Kongress für Orthopädie & Traumatologie; 12.-14. Mai, 2022; Graz, Austria. [Poster]

 

Seidel, M; Leithner, A; Kashofer, K; Moser, T; Thueringer, A; Liegl-Atzwanger, B; Szkandera, J; Benesch, M; El-Heliebi, A; Heitzer, E Ewing sarcoma and liquid biopsy: plasma ctDNA quantification by ddPCR for monitoring residual disease
21st General Meeting of the International Society of Limb Salvage; IL5. 2022; 11-11.-21st General Meeting of the International Society of Limb Salvage; SEP 6-9, 2022; Los Angeles, USA. [Oral Communication]

 

Seidel, MG; Leithner, A; Kashofer, K; Moser, T; Theuringer, A; Liegl-Atzwanger, B; Benesch, M; Szkandera, J; El-Heliebi, A; Heitzer, E Liquid biopsy for monitoring paediatric Ewing sarcoma patients.
Abstract Book of the 34th Annual Meeting of the European Musculoskeletal Oncology Society (EMSOS). 2022; 27--34th Annual Meeting of the European Musculoskeletal Oncology Society (EMSOS); OCT 17-19, 2022; London, GREAT BRITAIN. [Oral Communication]

 

Smolle, M; van de Sande, M; Callegaro, D; Wunder, J; Hayes, A; Leitner, L; Bergovec, M; Tunn, PU; Panotopoulos, J; Willegger, M; Windhager, R; Leithner, A; Haas, R; Szkandera, J Szkandera Entwicklung eines individuellen Nachsorgeschemas für Patienten mit primär lokalisierten, G2 und G3 Weichteilsarkomen der Extremitäten
Abstractband 1. Österreichischer Kongress für Orthopädie & Traumatologie. 2022; 48--1. Österreichischer Kongress für Orthopädie & Traumatologie; MAY 12-14, 2022; Graz, AUSTRIA. [Oral Communication]

 

Smolle, M; van de Sande, M; Tunn, PU; Hayes, A; Bergovec, M; Willegger, M; Windhager, R; Szkandera, J; Leithner, A Analyse der prognostischen Vorhersagekraft der 7. und 8. Version der AJCC-Klassifikation für Weichteilsarkome
Abstractband 1. Österreichischer Kongress für Orthopädie & Traumatologie. 2022; -1. Österreichischer Kongress für Orthopädie & Traumatologie; 12.-14. Mai, 2022; Graz, Austria. [Oral Communication]

 

Smolle, MA; Helmberg, W; Barth, DA; Sareban, N; Szkandera, J; Liegl-Atzwanger, B; Leithner, A; Pichler, M Prognostic Effect Of Allogeneic Red Blood Cell Transfusions In Soft Tissue Sarcoma Patients. A Retrospective Study.
Advanced Scientific Programme EFORT Congress. 2022; -EFORT Annual Congress; JUN 22-24, 2022; Lisbon, PORTUGAL. [Oral Communication]

 

Smolle, MA; Helmberg, W; Barth, DA; Sareban, N; Szkandera, J; Liegl-Atzwanger, B; Leithner, A; Pichler, M Einfluss der perioperativen Erythrozytenkonzentrat-Gabe auf die Prognose von Weichteilsarkom-patient*Innen. Eine retrospektive Studie.
Abstractband DKOU 2022. 2022; -Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU); OCT 25-28, 2022; Berlin, GERMANY. [Oral Communication]

 

Smolle, MA; Kogler, A; Friesenbichler, J; Bergovec, M; Castellani, C; Till, H; Benesch, M; Szkandera, J; Smolle-Jüttner, FM; Leithner, A Impact of pulmonary metastasectomy on outcome of bone sarcoma patients with lung metastases. A retrospective, IPTW- weighted analysis.
Abstract book of the 21st General Meeting of the International Society of Limb Salvage. 2022; -21st General Meeting of the International Society of Limb Salvage; SEP 6-9, 2022; Los Angeles, USA. [Oral Communication]

 

Smolle, MA; Musser, E; Bergovec, M; Friesenbichler, J; Wibmer, CL; Leitner, L; Sorensen MS; Petersen, MM; Brcic, I; Szkandera, J; Scheipl, S; Leithner, A External validation of the 2013-spring model for survival prediction in surgically treated patients with metastases to the appendicular skeleton.
Abstract Book of EMSOS 2022. 2022; -34th Annual Meeting of the European Musculo Skeletal Oncology Society; OCT 17-19, 2022; London, UNITED KINGDOM. [Oral Communication]

 

Smolle, MA; Van De Sande, M; Jeys, L; Bonenkamp, H; Pollock, R; Keller, Johnny; Tunn, PU; Haas, R; Van Ginkel, RJ; Verhoef, C; Leithner, A; Szkandera, J Impact Of Neoadjuvant And Adjuvant Radiotherapy On The Outcome Of Soft Tissue Sarcoma Patients. A Retrospective, Multicentre Study.
Advanced Scientific Programme EFORT Annual Congress. 2022; -EFORT Annual Congress; JUN 22-24, 2022; Lisbon, PORTUGAL. [Oral Communication]

 

Smolle, MA; van de Sande, M; Tunn, PU; Hayes, A; Bergovec, M; Smith HG; Niethard, M; Windhager, R; Szkandera, J; Leithner, A Prognostic accuracy of 7th and 8th AJCC classification for soft tissue sarcomas. Results from a retrospective, multi-centre study.
Abstract book of the 21st General Meeting of the International Society of Limb Salvage. 2022; -21st General Meeting of the International Society of Limb Salvage; SEP 6-9, 2022; Los Angeles, USA. [Oral Communication]

 

Szkandera, J Registerstudie Sarkom Österreich
Weichteilsarkome- interdisziplinäres onkologisches Symposium; MAR 11, 2022; Linz, AUSTRIA. 2022. [Oral Communication]

 

Szkandera, J Interaktive Fallvorstellungen zur interdisziplinären Behandlung von Knochen- und Weichgewebssarkomen
Sarkomkonferenz 2022; SEPT 22-24, 2022; Mannheim, DEUTSCHLAND. 2022. [Oral Communication]

 

Szkandera, J Therapie seltener Subtypen: wo gibt es Abweichungen von den Standards?
Jahrestagung DGHO, ÖGHO, SGMO, SGH; OKT 7-10; Vienna, AUSTRIA. 2022. [Oral Communication]

 

Szkandera, J Rückblick/Update Systemtherapie
Rückblick/Update Weichgewebssarkome 2022 "post-CTOS", Deutsche Sarkomstiftung; DEZ 14, 2022; Virtuell. 2022. [Oral Communication]

 

Szkandera, J Do we have clear standards for either pre- or postop radiation therapy?
Soft tissue sarcoma: generating evidence and sharing experience; APRIL 22-23, 2022; Madrid, Spanien. 2022. [Oral Communication]

 

Szkandera, J Perioperative Therapie (Neue Therapieoptionen-Sarkome)
OeGHO & AHOP-Frühjahrstagung 2022; APR 8-10, 2022; Graz, AUSTRIA. 2022. [Oral Communication]

 

Smolle, M; Woelfel, J; Acem, I; Van De Sande, MAJ; Jeys, L; Bonekamp, H; Pollock, R; Keller, J; Tunn, PU; Haas, R; Van Ginkel, RJ; Verhoef, C; Posch, F; Liegl-Atzwanger, B; Moustafa-Hubmer, D; Jost, PJ; Leithner, A; Szkandera J Neoadjuvant and adjuvant radiotherapy decreases the risk of local recurrence and adjuvant chemotherapy improves overall survival in a multicentre cohort of 2184 extremity soft tissue sarcoma patients
CTOS Abstract Book. 2021; -CTOS (Connective Tissue Oncology Society); NOV 10-13; Toronto, CANADA. [Oral Communication]

 

Smolle, MA; Bergovec, M; van de Sande, M; Tunn, PU; Hayes, A; Willegger, M; Windhager, R; Leithner, A; Szkandera, J Prognostic Accuracy Of The 7th And 8th Version Of The AJCC-Classification For Soft Tissue Sarcoma.
Virtual EFORT Congress 2021. 2021; -Virtual EFORT Congress 2021; JUN 30 - JUL 2, 2021; Rolle, SWITZERLAND. [Onlinepräsentation]

 

Smolle, MA; Herbsthofer, L; Goda, M; Granegger, B; Brcic, I; Bergovec, M; Scheipl, S; Prietl, B; El-Heliebi, A; Pichler, M; Gerger, A; Posch, F; Tomberger, M; Lopez-Garcia, P; Feichtinger, J; Baumgartner, C; Leithner, A; Liegl-Atzwanger, B; Szkandera, J Influence of tumor infiltrating immune cells on local control rate, distant metastasis, and survival in patients with soft tissue sarcoma
EMSOS Abstract Book. 2021; -EMSOS Annual Meeting 2021; DEC 1-3; Graz, AUSTRIA . [Oral Communication]

 

Smolle, MA; Herbsthofer, L; Granegger, B; Goda, M; Brcic, I; Bergovec, M; Scheipl, S; Prietl, B; Pichler, M; Gerger, A; Rossmann, C; Riedl, J; Tomberger, M; Lopez-Garcia, P; El-Heliebi, A; Leithner, A; Liegl-Atzwanger, B; Szkandera, J Einfluss von regulatorischen T-Zellen auf die Prognose von Weichteilsarkompatienten. Retrospektive, klinisch-pathologische Studie.
Abstract-Book der Sarkomkonferenz 2021. 2021; -Sarkomkonferenz; NOV 18-20, 2021; Berlin, GERMANY. [Oral Communication]

 

Smolle, MA; Herbsthofer, L; Granegger, B; Goda, M; Brcic, I; Bergovec, M; Scheipl, S; Prietl, B; Pichler, M; Gerger, A; Rossmann, C; Riedl, J; Tomberger, M; Lopez-Garcia, P; El-Heliebi, A; Leithner, A; Liegl-Atzwanger, B; Szkandera J T-regulatory cells predict clinical outcome in soft tissue sarcoma patients. A clinico-pathological study
CTOS Abstract Book. 2021; -CTOS (Connective Tissue Oncology Society) - 2021 Annual Meeting; NOV 10-13; Toronto, CANADA. [Poster]

 

Smolle, MA; van de Sande, M; Callegaro, D; Wunder, J; Hayes, A; Bergovec, M; Tunn, PU; Windhager, R; Liegl-Atzwanger, B; Andreou, D; Leithner, A; Gronchi, A; Haas, R; Szkandera J Flexible Parametric Competing Risk Regression Models As Novel Approach To Predict Risks Of LR And DM In Patients With High-Grade Extremity Soft Tissue Sarcoma.
Virtual EFORT Congress 2021. 2021; -Virtual EFORT Congress 2021; JUN 30 - JUL 2, 2021; Rolle, SWITZERLAND. [Onlinepräsentation]

 

Smolle, MA; van de Sande, M; Tunn, PU; Hayes, A; Bergovec, M; Willegger, M; Szkandera, J; Leithner, A Comparison of the 7th and 8th version of the AJCC-classification for soft tissue sarcoma.
Abstract book of the EMSOS 2021. 2021; -EMSOS Annual Meeting 2021; DEC 1-3, 2021; Graz, AUSTRIA. [Onlinepräsentation]

 

Smolle, MA; van de Sande, M; Tunn, PU; Hayes, A; Bergovec, M; Windhager, R; Szkandera, J; Leithner, A Prognostische Aussagekraft der 7. und 8. Version des AJCC-Staging-Systems für Weichteilsarkome der Extremitäten
Webprogramm DKOU 2021. 2021; -Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU); OCT 26-29, 2021; Berlin, GERMANY. [Poster]

 

Smolle, MA; van de Sande, M; Tunn, PU; Willegger, M; Leithner, A; Haas, R; Szkandera, J Individualisierte Nachsorge von Patienten mit High-Grade Weichteilsarkomen der Extremitäten - Ergebnisse einer retrospektiven Studie mit 3016 Patienten.
Webprogramm DKOU 2021. 2021; -Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU); OCT 26-29, 2021; Berlin, GERMANY. [Oral Communication]

 

Smolle, MA; Woelfel, J; Acem, I; van de Sande, M; Jeys, L; Bonekamp, H; Pollock, R; Keller, J; Tunn, PU; Haas, R; van Ginkel, RJ; Verhoef, C; Posch, F; Liegl-Atzwanger, B; Moustafa-Hubmer, D; Jost, P; Leithner, A; Szkandera, J Effect of Neoadjuvant and Adjuvant Radiotherapy on Local Recurrence, Distant Metastasis, and Overall Survival in Extremity Soft Tissue Sarcoma.
Abstract Book of the EMSOS 2021. 2021; -EMSOS Annual Meeting 2021; DEC 1-3, 2021; Graz, AUSTRIA. [Onlinepräsentation]

 

Szkandera, J Sarkome mit CIC-DUX Translokation - Behandlung analog Ewing oder "high grade Weichgewebssarkom"
Sarkomkonferenz 2021; NOV 18-20, 2021; Berlin, DEUTSCHLAND. 2021. [Oral Communication]

 

Szkandera, J Challenges in immunotherapy in sarcoma
European Congress of Radiology 2021; MARCH 3-7; Vienna, AUSTRIA . 2021. [Oral Communication]

 

Szkandera, J Immunotherapy incl. gene cell therapy: An overview
11th SPAEN Annual Conference for Organizations Representing Patients with Sarcomas, GIST and Desmoids; April 22-24, 2021; Virtuell. 2021. [Science to Public]

 

Szkandera, J Progress: Fortschreiten der Erkrankung unter medikamentöser Therapie Was ist Progress, wie klärt man ihn systematisch ab, was kann man tun?
1. TriNationales GIST-Patienten-Forum; MARCH 26-27; Berlin, DEUTSCHLAND. 2021. [Science to Public]

 

Szkandera, J Soft tissue sarcoma
EMSOS Annual Meeting; 1-3 DEC, 2021; Graz, Austria. 2021. [Oral Communication]

 

Woltsche, JN; Leithner, A; Smolle, MA; Szkandera, J; Maier, A; Liegl-Atzwanger, B; Smolle-Jüttner, FM Late metastasis in Ewing sarcoma.
Abstractbook EMSOS 2021. 2021; -EMSOS 33rd Annual Meeting; DEC 1-3, 2021; Graz, AUSTRIA. [Poster]

 

Brcic, I; Godschachner, TM; Bergovec, M; Igrec, J; Scheipl, S; Kashofer, K; Leithner, A; Szkandera, J; Liegl-Atzwanger, B Use of pant-TRK immunohistochemistry for identification of NTRK fusions in mesenchymal neoplasms - real life experience.
Virchows Archiv. 2020; 477(1):S19--32nd Congress of the ESP and XXXIII International Congress of the IAP; DEZ 5-9, 2020; Glasgow. [Onlinepräsentation]

 

Szkandera, J Systemic treatment of soft tissue sarcoma
The Possibilities of Diagnosing and Treating Sarcomas in the Modern Times ; OKT 29, 2020; Virtuell. 2020. [Keynote lecture]

 

Szkandera, J Update „Immun- und Genzell-Therapien“.
2. Online-Symposium 2020: Weichgewebssarkome, Deutsche Sarkomstiftung; NOV 25, 2020; Virtuell. 2020. [Oral Communication]

 

Szkandera, J The value of adoptive cell therapy and immunotherapy.
ONCOL RES TREAT. 2020; 43(SUPPL 4):10-10.-DGHO; OKT 09-12, 2021; Virtuell. [Oral Communication]
Web of Science

 

Szkandera, J Stellenwert von Zell- und Immuntherapien.
DGHO; OKT 9-11, 2020; virtuell. 2020. [Oral Communication]

 

Aziz, F; Stelzl, A; Riedl, J; Smolle, M; Stojakovic, T; Posch, F; Terbuch, A; Pichler, M; Leithner, A; Stoger, H; Liegl-Atzwanger, B; Stotz, M; Gerger, A; Szkandera, J; Sourij, H Diabetes is a predictor for survival in soft tissue sarcoma patients
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S477-S477. [Poster]
Web of Science

 

Aziz, F; Stelzl, A; Riedl, JM; Smolle, MA; Stojakovic, T; Posch, F; Terbuch, A; Pichler, M; Leithner, A; Stoger, H; Liegl-Atzwanger, B; Stotz, M; Gerger, A; Szkandera, J; Sourij, H Association of serum glucose levels with disease free survival in soft tissue sarcoma patients
DIABETOLOGIA. 2019; 62: S562-S563.-55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 16-20, 2019; Barcelona, SPAIN. [Poster]
Web of Science

 

Barth, D; Riedl, JM; Posch, F; Smolle, MA; Kasparek, AK; Niedrist, T; Szkandera, J; Stöger, H; Pichler, M; Gerger, A; Stotz, M Critical evaluation of platelet size as a prognostic biomarker in colorectal cancer across multiple treatment settings: a retrospective cohort study.
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology. 2019; -OeGHO Frühjahrstagung 2019; APR 11-13; Linz, AUSTRIA. [Poster]

 

Kocher, F; Seeber, A; Weiss, L; Romeder, F; Szkandera, J; Kuhr, T; Kostner, S; Pichler, P; Jager, T; Greil, R; Brodowicz, T Olaratumab plus anthracyline in advanced/metastatic soft tissue sarcoma: Data of real-world utilization in Austria.
J CLIN ONCOL. 2019; 37(15):-Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO); MAY 31-JUN 04, 2019; Chicago, IL. [Poster]
Web of Science

 

Pondorfer, P; Mollnar, S; Kasparek A; Reinisch, S; Moik, F; Stolz, M; Halm, M; Szkandera, J; Gerger; A; Kapp, K; Partl, R; Vasicek, S; Weiland, T; Pichler, M; Störer, H; Posch, F; Thurnher, D; Induction chemotherapy and chemoradiation for patients with advanced HNSCC: A systematic analysis of acute treatment toxicities and their management
https://www.hno.at/fileadmin/userdaten/HNO_Kongress_2019/HNO2019_Abstractband_web_20190828.pdf. 2019; -Österreichischer HNO Kongress; Sep 11-15, 2019; Salzburg. [Oral Communication]
FullText

 

Pondorfer, P; Molnar, S Kasparek, A.-K.; Reinisch, S; Moik, F; Stotz, M; Halm, M; Szkandera, J; Berger, A; Kapp, K.S; Vasicek, S; Weiland, T; Pichler, M; Störer, H; Posch, F; Thurnher, D; HPV infection as a predictive biomarker for response to induction chemotherapy and concomitant chemoradiation in patients with advanced head and neck squamous cell carcinoma
CEORL HNS; JUN 30, 2019; Brussels. 2019. [Oral Communication]
FullText

 

Riedl, J; Stelzl, A; Aziz, F; Smolle, M; Stojakovic, T; Posch, F; Terbuch, A; Pichler, M; Leithner, A; Stöger, H; Liegl-Atzwanger, B; Stotz, M; Gerger, A; Sourij, H; Szkandera, J Elevated mean glucose level predicts decreased disease free survival in soft tissue sarcoma patients.
32nd Annual Meeting of the European Musculo Skeletal Oncology Society. 2019; -32nd Annual Meeting of the European Musculo Skeletal Oncology Society; MAY 15-17, 2019; Florence, ITALY . [Poster]
FullText

 

Riedl, JM; Stelzl, A; Aziz, F; Smolle, MA; Stojakovic, T; Posch, F; Terbuch, A; Pichler, M; Leithner, A; Stöger, H; Liegl-Atzwanger, B; Stotz,M; Gerger, A; Sourij, H; Szkandera, J Elevated mean glucose level predicts decreased disease free survival in soft tissue sarcoma patients.
OeGHO- & AHOP-Frühjahrstagung 2019; 11.04.2019 - 13.04.2019; Linz, Austria. 2019. [Oral Communication]

 

Smolle, MA; Schaffler, A; Leithner, A; van Praag, VM; Bergovec, M; Szkandera, J; Liegl-Atzwanger, B; Niethard, M; Tunn, PU; van de Sande, M; Andreou D Incidence and outcome of abdominal metastases in soft tissue sarcoma. Results of a multicentre study.
Abstract Book of the 32. Annual Meeting of the European Musculoskeletal Tumour Society (EMSOS). 2019; -32. Annual Meeting of the European Musculoskeletal Tumour Society (EMSOS); MAY 15-17, 2019; Florence, ITALY. [Oral Communication]

 

Smolle, MA; Schaffler, A; Leithner, A; van Praag, VM; Bergovec, M; Szkandera, J; Liegl-Atzwanger, B; Niethard, M; Tunn, PU; van de Sande, M; Andreou D Abdominelle Metastasen bei Weichteilsarkomen. Ergebnisse einer Multicenter-Studie mit 854 Patienten.
35. Jahrestagung der Österreichischen Gesellschaft für Orthopädie und Orthopädische Chirurgie (ÖGO); MAY 22-24, 2019; Wels, AUSTRIA. 2019. [Oral Communication]

 

Smolle, MA; Schaffler, A; van Praag, VM; Bergovec, M; Szkandera, J; Liegl-Atzwanger, B; Niethard, M; Tunn, PU; van de Sande, M; Leithner, A; Andreou, D Abdominal Metastases In Patients With Soft Tissue Sarcoma. Results Of A Multicentre Study Of 854 Patients.
20th EFORT Congress; JUN 5-7, 2019; Lisbon, PORTUGAL. 2019. [Oral Communication]

 

Smolle, MA; van de Sande, M; Callegaro, D; Wunder, J; Hayes, AJ; Leitner, L; Bergovec, M; Tunn, PU; van Praag, VM; Panotopoulos, J; Willegger, M; Windhager, R; Riedl, JM; Stotz, M; Gerger, A; Pichler, M; Stöger, H; Liegl-Atzwanger, B; Smolle, J; Leithner, A; Gronchi, A; Haas, RL; Szkandera, J Advancing soft-tissue sarcoma aftercare using flexible parametric survival models.
Abstract Book of the 32. Annual Meeting of the European Musculoskeletal Tumour Society (EMSOS). 2019; -32. Annual Meeting of the European Musculoskeletal Tumour Society (EMSOS); MAY 15-17, 2019; Florence, ITALY. [Oral Communication]

 

Smolle, MA; van de Sande, M; Callegaro, D; Wunder, J; Hayes, AJ; Leitner, L; Bergovec, M; Tunn, PU; van Praag, VM; Panotopoulos, J; Willegger, M; Windhager, R; Riedl, JM; Stotz, M; Gerger, A; Pichler, M; Stöger, H; Liegl-Atzwanger, B; Smolle, J; Leithner, A; Gronchi, A; Haas, RL; Szkandera, J Individualising soft tissue sarcoma aftercare with flexible parametric survival modelling.
Webabstracts of the 20th General Meeting of the International Society of Limb Salvage (ISOLS). 2019; -20th General Meeting of the International Society of Limb Salvage (ISOLS); SEP 11-14, 2019; Athens, GREECE. [Oral Communication]

 

Szkandera, J Systematische Behandlung der Weichteilsarkome
5. Interdisziplinäre Fortbildung des CCC-Graz, Subzentrum Sarkome; FEB 7, 2019; Graz, AUSTRIA. 2019. [Oral Communication]

 

Szkandera, J Which therapies for which molecular subtypes?
ONCOL RES TREAT. 2019; 42: 239-240.
Web of Science

 

Szkandera, J State of the Art in der Therapie von Knochenmetastasen
AMSOS; NOV 22; Innsbruck, AUSTRIA. 2019. [Oral Communication]

 

Szkandera, J Case Presentation.
Deutsche Sarkomkonferenz; MARCH, 21-23, 2019; Berlin, AUSTRIA. 2019. [Oral Communication]

 

Szkandera, J Welche Therapien für welche molekularen Subgruppen?
Oncol Res Treat 2019;42(suppl 4):1-33610.1159/000502425. 2019; -DGHO; OCT 11-14, 2019; Berlin, GERMANY. [Oral Communication]

 

Szkandera, J Multi-Disciplinary Care
POST-CTOS; NoOV 29-30, 2019; Dresden, Germany. 2019. [Oral Communication]

 

Szkandera, J; Smolle, MA; Schaffler, AJ; Leithner, A; van Praag, V; Bergovec, M; Liegl-Atzwanger, B; Niethard, M; Tunn, PU; van de Sande, M; Andreou, D Abdominal metastases of soft tissue sarcoma. Incidence and outcome in 769 patients
CTOS; NOV 13-16, 2019; Tokyo, JAPAN. 2019. [Poster]

 

Szkandera, J; Smolle, MA; van de Sande, M; Callegaro, D; Wunder, J; Hayes, A; Leitner, L; Bergovec, M; Tunn, PU; van Praag, V; Panotopoulos, J; Willegger, M; Windhager, R; Riedl, J; Stotz, M; Gerger, A; Pichler, M; Dijkstra, S; van Houdt, W; Stöger, H; Liegl-Atzwanger, B; Smolle, J; Leithner, A; Gronchi, A; Haas, R Individualization of follow-up in patients with high-grade soft tissue sarcoma
CTOS; NOV 13-16, 2019; Tokyo, JAPAN. 2019. [Poster]

 

Brcic, I;, Brodowicz, T; Cerroni, L; Kashofer, K; Serbanescu, GL; Kasseroler, MT; Amann, G; Szkandera, J; Leithner, A; Liegl-Atzwanger, B Undifferentiated round cell sarcomas with CIC-DUX4 gene fusion in unusual locations – expanding the clinical spectrum
Der Pathologe. 2018; 39(5):481-481.-Herbsttagung 2018 der OeGPath/IAP Austria; SEP 27-28, 2018; Graz, Austria. [Poster]

 

Klöckl, MC; Kasparek, AK; Riedl, J; Moik ,F; Mollnar, S; Stotz, M; Szkandera, J; Terbuch, A; Gerger, A; Niedrist, T; Pichler, M; Bauernhofer T; Stöger H; Posch, F Estimated versus measured glomerular filtration rate to evaluate kidney function in patients with cancer undergoing cisplatin-based chemotherapy
Oncology Research and Treatment . 2018; 41(Suppl4):224-224.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; SEP 28- OCT 2, 2018; Vienna, AUSTRIA. (ISBN: 978-3-318-06425-4 ) [Poster]
Web of Science FullText

 

Leithner, A; Posch, F; Smolle, MA; Willegger, M; Tunn, PU; Goldenitsch, E; Liegl-Atzwanger B; Döller, C; Windhager, R; Szkandera, J Rethinking the follow-up of soft tissue sarcomas: a multicenter analysis of 835 cases.
Special APMSTS 2018 Issue of Journal of Bone and Soft Tissue Tumors. 2018; 4(2):-12th Asian Pacific Musculoskeletal Tumour Society (APMSTS) Meeting; OCT 4 -7, 2018; Jaipur, INDIA. [Oral Communication]

 

Leithner, A; van Praag, V; Posch, F; Bergovec, M; Leitner, L; Friesenbichler, J; Heregger, R; Smolle-Juttner, FM; Fiocco, M; van de Sande, M; Riedl, J; Pichler, M; Gerger, A; Szkandera, J; Stoger, H; Liegl-Atzwanger, B; Smolle, MA Efficacy of metastasectomy on survival in patients with metachronous soft tissue sarcoma-metastasis: Results of a bi-centre study including 135 patients
ANN ONCOL. Abstract Book of the 43rd ESMO Congress (ESMO 2018) 19–23 October 2018, Munich, Germany. 2018; 29(S8):-43rd ESMO Congress (ESMO); OCT 19-23, 2018; Munich, GERMANY. [Poster]
Web of Science

 

Leithner, A;Smolle, MA; Szkandera, J; Posch, F; Liegl-Atzwanger, B; Scheipl, S; Bergovec, M Spezialisierte Tumororthopädie.
Innovative, multimodale Therapiekonzepte bei Sarkomen; FEB 28, 2018; Vienna, AUSTRIA. 2018. [Oral Communication]

 

Mollnar, S; Pondorfer, P; Reinisch, S; Moik, F; Halm, M; Kasparek, AK; Klockl, MC; Stotz, M; Szkandera, J; Gerger, A; Vasicek, S; Weiland, T; Pichler, M; Stoger, H; Thurnher, D; Posch, F Definitive chemoradiotherapy with or without induction chemotherapy for unresectable squamous cell carcinoma of the head & neck: a propensity-score analysis
ONCOL RES TREAT. 2018; 41: 248-248. [Poster]
Web of Science

 

Smolle, MA; Bergovec, M; Posch, F; Szkandera, J; Liegl-Atzwanger, B; Smolle-Jüttner, FM; van de Sande, M; Leithner, A Metastasektomie bei Weichteilsarkomen.
8th Annual Meeting of the Austrian Musculo-Skeletal Oncology Society; DEC 7, 2018; Wiener Neustadt, AUSTRIA. 2018. [Oral Communication]

 

Smolle, MA; Tunn, PU; Goldenitsch, E; Posch, F; Szkandera, J; Bergovec, M; Liegl-Atzwanger, B; Leithner, A Influence of unplanned excisions on overall-survival in patients with soft tissue sarcoma. Results of a multicentre-study including 728 patients.
Special APMSTS 2018 Issue of Journal of Bone and Soft Tissue Tumors. 2018; 4(2):-12th Asian Pacific Musculoskeletal Tumour Society (APMSTS) Meeting; OCT, 4-7, 2018; Jaipur, INDIA. [Oral Communication]

 

Smolle, MA; Tunn, PU; Goldenitsch, E; Posch, F; Szkandera, J; Bergovec, M; Liegl-Atzwanger, B; Leithner, A Outcome following unplanned excision in soft tissue sarcoma: Results of a multicentre study including 728 patients
ANN ONCOL. Abstract Book of the 43rd ESMO Congress (ESMO 2018) 19–23 October 2018, Munich, Germany. 2018; 29(S8):-43rd ESMO Congress (ESMO); OCT 19-23, 2018; Munich, GERMANY. [Oral Communication]
Web of Science

 

Smolle, MA; van Praag, V; Posch, F; Bergovec; M; Leitner, L; Friesenbichler, J; Heregger, R; Smolle-Jüttner, FM; Fiocco, M; van de Sande, M; Riedl, J; Pichler, M; Gerger, A; Szkandera, J; Stöger, H; Liegl-Atzwanger, B; Leithner, A Effect of metastasectomy on overall-survival of patients with metachronous metastasis of STS. A bi-centre study including 135 patients.
12th Asian Pacific Musculoskeletal Tumour Society (APMSTS) Meeting; OCT 4-7, 2018; Jaipur, INDIA. 2018. [Poster]

 

Smolle, MA; van Praag, V; Posch, F; Bergovec, M; Szkandera, J; Liegl-Atzwanger, B; van de Sande, M; Leithner, A Einfluss der Metastasektomie auf das Überleben von Patienten mit metastasiertem Weichteilsarkom. Resultate einer Bi-Center Studie.
Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU); OCT 23-26, 2018; Berlin, GERMANY. 2018. [Oral Communication]

 

Smolle, MA; Van Praag, VM; Posch, F; Bergovec, M; Heregger, R; Szkandera, J; Liegl-Atzwanger, B; Smolle-Jüttner, FM; van de Sande, MA; Leithner, A. Metastasectomy in soft tissue sarcoma is associated with a post-metastasis survival benefit. Results from a bi-center study including 135 patients.
Final Program of the 2018 CTOS Annual Meeting. 2018; 435--CTOS Annual Meeting; NOV 14-17, 2018; Rome, ITALY. [Poster]

 

Smolle, MA; van Praag, VM; Posch, F; Bergovec, M; Leitner, L; Friesenbichler, J; Heregger, R; Riedl, JM; Pichler, M; Gerger, A; Szkandera, J; Stöger, H; Smolle-Jüttner, FM; Liegl-Atzwanger, B; Fiocco, M; van de Sande, MAJ; Leithner, A Metachronous metastasis of soft tissue sarcoma: Benefit of metastasectomy. A bi-centre study.
Abstractbook of the EMSOS 2018. 2018; -31st EMSOS Meeting; MAY 9-11, 2018; Amsterdam, THE NETHERLANDS. [Oral Communication]

 

Szkandera, J Welche Therapien beilegen molekularen Subgruppen?
POST-CTOS 2018; OCT 30-DEC 1, 2018; Frankfurt, Germany. 2018. [Oral Communication]

 

Szkandera, J Case Presentation
Deutsche Sarkomkonferenz; MARCH, 15-17, 2018; Berlin, GERMANY. 2018. [Oral Communication]

 

Szkandera, J Weichteilsarkome – Update 2018
OEGHO; APR 19-21, 2018; Klagenfurt, AUSTRIA. 2018. [Oral Communication]

 

Szkandera, J Case Presentation
AMSOS; DEZ 7, 2018; Wiener Neustadt. 2018. [Oral Communication]

 

Szkandera, J; Posch, F Wie lang und wie oft sollen wir die Weichteilsarkom-PatientInnen nach kurativer Resektion nachsorgen?
AMSOS; DEZ 7, 2018; Wiener Neustadt, AUSTRIA. 2018. [Oral Communication]

 

Bezan, A; Pasch, F; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Partl, R; Zurl, B; Kapp, K; Stager, H; Gerger, A; Stotz, M Clinical characterization of febrile neutropenia episodes in patients with testicular germ cell tumors.
J CLIN ONCOL. 2017; 35: -53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET; JUN 02-07, 2017; Chicago, IL. Doi: 10.1200/JCO.2017.35.15_suppl.e16038 [Oral Communication]
Web of Science FullText FullText_MUG

 

Leithner, A; Posch, F; Leitner, L; Liegl-Atzwanger, B; Pichler, M; Gerger, A; Bergovec, M; Szkandera, J Local Recurrence, Distant Metastasis, and Death in Patients with Soft Tissue Sarcoma after Curative Resection Using a Multi-state Model.
Abstractbook of 19th General Meeting of ISOLS. 2017; -ISOLS 2017; MAY 10-12, 2017; Kanazawa, JAPAN. [Oral Communication]

 

Leithner, A; Smolle, M; Szkandera, J; Liegl-Atzwanger, B; Lohberger, B; Scheipl, S; Bergovec, M Shaping the future of soft tissue sarcoma care.
International Student Congress; MAY 25, 2017; Graz, AUSTRIA. 2017. [Keynote lecture]

 

Leithner, A; Smolle, M; Szkandera, J; Liegl-Atzwanger, B; Lohberger, B; Scheipl, S; Bergovec, M Shaping the future of soft tissue sarcoma care.
Carola Davila University of Medicine and Pharmacy Congress, 4th Edition; JUN 3, 2017; Bucharest, ROMANIA. 2017. [Keynote lecture]

 

Leithner, A; Smolle, M; Szkandera, J; Liegl-Atzwanger, B; Lohberger, S; Scheipl, S; Bergovec, M Shaping the future of soft tissue sarcoma care.
53º Congreso Chileno de Ortopedia y Traumatología; NOV 15-18, 2017; Vina del mar, CHILE. 2017. [Keynote lecture]

 

Leithner, A; Smolle, M; Szkandera, J; Liegl-Atzwanger, B; Lohberger, S; Scheipl, S; Bergovec, M. Shaping the future of sarcoma care
Graduate Seminar of the Department of Orthopaedic Surgery, University Medical Centre Ljubljana, Slovenia; JUN 12, 2017; Ljubljana, SLOVENIA. 2017. [Keynote lecture]

 

Leithner, A; Smolle, MA; Szkandera, J; Liegl-Atzwanger, B; Bergovec, M Chancen und Grenzen der Palliativen Chirurgie
Sarkomkonferenz; MAR 16-18, 2017; Berlin, GERMANY. 2017. [Oral Communication]

 

Leithner, A; Smolle, MA; Szkandera, J; Liegl-Atzwanger, B; Lohberger, B; Scheipl, S; Bergovec, M. Neue Aspekte in der Therapie von Weichgewebssarkomen.
Jahrestagung der DGPRÄC, ÖGPÄRC, VDÄPC; SEPT 16, 2017; Graz, AUSTRIA. 2017. [Oral Communication]

 

Leitner, L; Posch, F; Liegl-Atzwanger, B; Döller, C; Friesenbichler, J; Bergovec, M; Leithner, A; Szkandera, J; Evaluierung der Wirksamkeit von adjuvanter Bestrahlung auf Lokalrezidiv-Rate, Metastasierung und Gesamtüberleben von Patienten mit lokalisierten Weichteilsarkomen.
Abstractbook des DKOU 2017 in Berlin. 2017; -DKOU Berlin; OCT 24-27, 2017; Berlin, GERMANY. [Oral Communication]

 

Leitner, L; Posch, F; Liegl-Atzwanger, B; Pichler, M; Gerger, A; Bergovec, M; Leithner, A; Szkandera, J; Lokalrezidiv-Rate, Metastasierung und Mortalität nach Resektion lokalisierter Weichteilsarkome in kurativer Intention: Ein multi-state Model.
Abstractbook des DKOU 2017 in Berlin. 2017; -DKOU Berlin; OCT 24-27, 2017; Berlin, GERMANY. [Oral Communication]

 

Partl R, Bezan A, Posch F, Zurl B, Bauernhofer T, Pichler M, Szkandera J, Hutterer G, Pummer K, Kapp KS, Stöger H, Gerger A, Stotz M Untersuchung von Risikofaktoren für die Entwicklung einer febrilen Neutropenie nach cisplatinhältiger Chemotherapie bei Patienten mit testikulären Keimzelltumoren.
Konferenzsband. 2017; -34. Jahrestagung der Österreichischen Gesellschaft für Radioonkologie, Radiobiologie und Medizinische Radiophysik; OCT 5-6; Linz, AUSTRIA. [Oral Communication]

 

Partl R, Posch F, Döller C, Riedl JM, Smolle M, Leitner L, Bergovec M, Liegl-Atzwanger B, Stotz M, Bezan A, Gerger A, Pichler M, Kapp KS, Stöger H, Leithner A, Szkandera J Untersuchung des Benefits der adjuvanten Radiotherapie in Bezug auf Lokalkontrolle, Fernmetastasierung und Überleben bei PatientInnen mit lokalisiertem Weichteilsarkom mittels vergleichender Effektivitätsanalyse
Abstractband. 2017; -34. Jahrestagung der Österreichischen Gesellschaft für Radioonkologie, Radiobiologie und Medizinische Radiophysik ; OCT 6-7; Linz, AUSTRIA. [Poster]

 

Posch, F; Leitner, L; Liegl-Atzwanger, B; Doeller, C; Pichler, M; Gerger, A; Bezan, A; Stotz, M; Bergovec, M; Stoeger, H; Leithner, A; Szkandera, J Benefit Of Adjuvant Radiotherapy For Local Control, Distant Metastasis, And Survival Outcomes In Patients With Localised Soft-Tissue Sarcoma: Comparative Effectiveness Analysis Of An Observational Cohort Study.
Abstractbook of 18th EFORT Congress. 2017; -18th EFORT Congress; MAY 31 - JUN 2, 2017; Vienna, AUSTRIA. [Poster]

 

Posch, F; Leitner, L; Stotz, M; Liegl-Atzwanger, B; Bezan, A; Pichler, M; Gerger, A; Bergovec, M; Stoeger, H; Leithner, A; Szkandera, J Local Recurrence, Distant Metastasis, And Survival In Patients With Soft-Tissue Sarcoma (STS) After Curative Resection: A Multi-State Model.
Abstractbook of 18th EFORT Congress. 2017; -18th EFORT Congress; MAY 31 - JUN 2, 2017; Vienna, AUSTRIA. [Poster]

 

Posch, F; Silina, K; Petrausch, U; Leibl, S; Muendlein, A; Moch, H; Siebenhuener, AR; Pestalozzi, BC; Riedl, JM; Stotz, M; Szkandera, J; Stoeger, H; Pichler, M; Stupp, R; Schraml, P; Gerger, A; Winder, T; The maturation stage of tumoral tertiary lymphoid structures to predict recurrence risk in localized colorectal cancer.
Journal of Clinical Oncology. 2017; 35 (15_suppl): e15083-e15083.-American Society of Clinical Oncology (ASCO) Annual Meeting; JUN 2-6, 2017; Chicago, IL, USA.
FullText

 

Posch, Florian; Riedl, Jakob; Leitner, Lukas; Liegl-Atzwanger, Bernadette; Doeller, Carmen; Bezan, Angelika; Stotz, Michael; Pichler, Martin; Gerger, Armin; Bergovec, Marko; Stoeger, Herbert; Leithner, Andreas; Szkandera, Joanna Benefit of adjuvant radiotherapy for local control, distant metastasis, and survival outcomes in patients with localized soft tissue sarcoma: Comparative effectiveness analysis of an observational cohort study.
Proceedings of the 30th Annual Meeting of the European Musculoskeletal Oncology Society (EMSOS), A-0001. 2017; 89--30th Annual Meeting of the European Musculoskeletal Oncology Society (EMSOS); APR 26-28, 2017; Budapest, HUNGARY. [Oral Communication]

 

Smolle, MA; Bergovec, M; Szkandera, J; Posch, F; Liegl-Atzwanger, B; Leithner, A Behandlung von Patienten mit metastasiertem Weichteilsarkom
34. Jahrestagung der Österreichischen Gesellschaft für Orthopädie und orthopädische Chirurgie; NOV 30 - DEZ 1, 2017; Vienna, AUSTRIA. 2017. [Oral Communication]

 

Smolle, MA; Tunn, PU; Goldenitsch, E; Posch, F; Szkandera, J; Bergovec, M; Liegl-Atzwanger, B; Leithner, A Why Should Unplanned Excisions Best Be Avoided In Soft-Tissue Sarcomas? Results Of A Multi-Centre Study Including 728 Patients.
Abstractbook of 18th EFORT. 2017; -18th EFORT Congress; MAY 31 - JUN 2, 2017; Vienna, AUSTRIA. [Oral Communication]

 

Smolle, MA; Tunn, PU; Goldentisch E; Posch, F; Szkandera, J; Bergovec, M; Liegl-Atzwanger, B; Leithner, A Welche prognostische Bedeutung haben ungeplante Resektionen bei Weichteilsarkomen? Resultate einer multizentrischen, retrospektiven Studie mit 728 operativ versorgten Weichteilsarkom-Patienten.
Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU); OCT 24-27, 2017; Berlin, GERMANY. 2017. [Oral Communication]

 

Smolle, Maria; Bergovec, Marko; Szkandera, Joanna; Liegl-Atzwanger, Bernadette; Leithner, Andreas Treatment of STS patients developing metastasis: Should we be less or more aggressive?
Proceedings of the 30th Annual Meeting of the European Musculoskeletal Oncology Society (EMSOS), A-0244. 2017; 78--30th Annual Meeting of the European Musculoskeletal Oncology Society (EMSOS); APR 26-28, 2017; Budapest, HUNGARY. [Oral Communication]

 

Szkandera, J Case Presentation
Deutsche Sarkomkonferenz; MARCH, 16-18, 2017; Berlin, GERMANY. 2017. [Oral Communication]

 

Szkandera, J Aktuelles zur systemischen Therapie des Ewing-Sarkoms bei Erwachsenen
4. Interdisziplinäre Fortbildung des CCC-Graz, Subzentrum Sarkome; FEB 10, 2017; Graz, AUSTRIA. 2017. [Oral Communication]

 

Szkandera, J; Posch, F Benefit of adjuvant radiotherapy for local control, distant metastasis, and survival outcomes in patients with localized soft tissue sarcoma
EMSOS; APR 26-28, 2017; Budapest, HUNGARY. 2017. [Oral Communication]

 

Bezan, A; Posch, F; Ploner, F; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Gary, T; Samonigg, H; Beyer, J; Winder, T; Hermanns, T; Fankhauser, CD; Gerger, A; Stotz, M Risk stratification for venous thromboembolism in patients with testicular germ cell tumors
ÖGHO; March 17-19, 2016; Wien. 2016. [Oral Communication]

 

Bezan, A; Posch, F; Ploner, F; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Gary, T; Samonigg, H; Gerger, A; Stotz, M; 23 Risk stratification for venous thromboembolism in patients with testicular germ cell tumours
European Urology Supplements. 2016; 15(3):E23--European Association of Urology (EAU) Annual Meeting; MAR 11-15, 2016; Munich, GERMANY. [Oral Communication]
FullText

 

Gilg, MM; Sunitsch, S; Leitner, L; Szkandera, J; Leithner, A; Liegl, B Tumour-associated mortality and prognostic factors in myxofibrosarcoma.
Abstracts of EMSOS 2016. 2016; -29th Annual Meeting of the European Musculo-Skeletal Oncology Society; MAY 25-27, 2016; La Baule, FRANCE. [Oral Communication]

 

Gilg, MM; Wibmer, C; Amrein, K; Fahrleitner-Pammer, A; Berghold, A; Ferstl-Rohrbacher, A; Maurer-Ertl, W; Gerger, A; Leithner, A; Pichler, M; Szkandera, J Serum sclerostin levels in renal cell carcinoma patients with bone metastases.
Abstracts of EMSOS 2016. 2016; -29th Annual Meeting of the European Musculo-Skeletal Oncology Society; MAY 25-27, 2016; La Baule, FRANCE. [Poster]

 

Posch, F; Leitner, L; Liegl-Atzwanger, B; Wink, A; Stotz, M; Bezan, A; Pichler, M; Gerger, A; Bergovec, M; Stoeger, H; Leithner, A; Szkandera, J Benefit of adjuvant radiotherapy for local control, distant metastasis, and survival outcomes in patients with localized soft tissue sarcoma: Comparative effectiveness analysis of an observational cohort study
Abstracts of CTOS 2016. 2016; -CTOS (Connective Tissue Oncology Society); Nov 9-12; Lisbon, PORTUGAL. [Oral Communication]

 

Posch, F; Leitner, L; Stotz, M; Liegl-Atzwanger, B; Bezan, A; Pichler, M; Friesenbichler, J; Gerger, A; Stoeger, H; Leithner, A; Szkandera, J Conditional survival of patients with soft tissue sarcoma (STS) after curative resection
Abstracts of CTOS 2016. 2016; -CTOS (Connective Tissue Oncology Society); NOV 9-12; Lisbon, PORTUGAL. [Poster]

 

Posch, F; Leitner, L; Stotz, M; Liegl-Atzwanger, B; Bezan, A; Pichler, M; Gerger, A; Bergovec, M; Stoeger, H; Leithner, A; Szkandera, J Local recurrence, distant metastasis, and death in patients with soft tissue sarcoma (STS) after curative resection: A multi-state model
Abstracts of CTOS 2016. 2016; -CTOS (Connective Tissue Oncology Society); NO 9-12; Lisbon, PORTUGAL. [Poster]

 

Posch, F; Liegl-Atzwanger, B; Thalhammer, M; Stotz, M; Bezan, A; Mrsic, E; Samonigg, H; Pichler, M; Gerger, A; Szkandera, J Local recurrence, distant metastasis, adjuvant imatinib, and long-term survival outcomes in patients with gastrointestinal-stroma-tumors (GIST) after curative surgery: A multi-state model
ÖGHO; MARCH, 17-19, 2016; WIEN. 2016. [Oral Communication]

 

Smolle, MA; Goldenitsch, E; Machacek, F; Bezan, A; Pichler, M; Gerger, A; Bergovec, M; Stoeger, H; Leithner, A; Szkandera, J THERAPY AND OUTCOME OF PATIENTS FOLLOWING UNPLANNED EXCISIONS IN SOFT TISSUE SARCOMA: A MULTI- CENTRE EXPERIENCE.
Abstracts of CTOS 2016; P2-P185. 2016; -CTOS 2016; NOV 9-12, 2016; Lisbon, PORTUGAL. [Poster]

 

Smolle, MA; Posch, F; Szkandera, J; Bergovec, M; Leithner, A Der Einfluss von ungeplanten Resektionen auf das Überleben von Patienten mit Weichteilsarkomen: Eine retrospektive Datenanalyse.
33. Jahrestagung Österreichische Gesellschaft für Orthopädie und Orthopädische Chirurgie; SEP 29 - OCT 1, 2016; Villach, AUSTRIA. 2016. [Oral Communication]

 

Smolle, MA; Szkandera, J; Leithner, A UNPLANNED EXCISIONS IN SOFT TISSUE SARCOMA: INFLUENCE ON THERAPY AND PATIENTS’ PROGNOSIS.
Book of Abstracts; 18. 2016; -11th CEOC; JUN 9-10, 2016; Prag, CZECH REPUBLIC. [Oral Communication]

 

Smolle, MA; Szkandera, J; Leithner, A Evaluating the influence of unplanned excisions in soft tissue sarcomas on therapy and patient’s survival.
Abstracts of EMSOS 2016. 2016; -29th Annual Meeting of the European Musculo-Skeletal Oncology Society; MAY 25-27, 2016; La Baule, FRANCE. [Poster]

 

Szkandera, J Neues zur Sarkomtherapie
13. Kärntner- und steirisches Onkologiesymposium; JUN 17-19, 2016; Bad Kleinkirchheim, AUSTRIA. 2016. [Oral Communication]

 

Szkandera, J GIST Update
Onkologische Wintergespräche; JAN 15-16, 2016; Vienna, Austria. 2016. [Oral Communication]

 

Szkandera, J Systemische Therapie der Liposarkome
3. Interdisziplinäre Fortbildung des CCC-Graz, Subzentrum Sarkome; FEB 26, 2016; Graz, AUSTRIA. 2016. [Oral Communication]

 

Szkandera, J; Posch, F Benefit of adjuvant radiotherapy for local control, distant metastasis, and survival outcomes in patients with localized soft tissue sarcoma
CTOS; NO 9-12; Lissabon, PORTUGAL. 2016. [Oral Communication]

 

Szkandera, J; Posch, F; Stotz, M; Liegl-Atzwanger, B; Pichler, M; Gerger, A; Friesenbichler, J; Leithner, A Local recurrence, distant metastasis, and death in patients with soft tissue sarcoma (STS) after curative resection: A multi-state model.
Abstracts of EMSOS 2016. 2016; -29th Annual Meeting of the European Musculo-Skeletal Oncology Society; MAY 25-27, 2016; La Baule, FRANCE. [Oral Communication]

 

Szkandera, J; Posch, F; Stotz, M; Liegl-Atzwanger, B; Pichler, M; Gerger, A; Friesenbichler, J; Leithner, A Conditional survival of patients with soft tissue sarcoma (STS) after curative Resection.
Abstracts of EMSOS 2016. 2016; -29th Annual Meeting of the European Musculo-Skeletal Oncology Society; MAY 25-27, 2016; La Baule, FRANCE. [Oral Communication]

 

Thomas Winder, Michael Stotz, Alexander Rheinhard Siebenhuener, Konstantin Schlick, Teresa Magnes, Panagiotis Samaras, Joanna Szkandera, Pierre-Alain Clavien, Daniel Neureiter, Richard Greil, Bernhard C. Pestalozzi, Armin Gerger, Alexander Egle, Martin Pichler The fibrinogen/CRP ratio as a novel prognostic parameter for pancreatic cancer patients
ASCO 2016. 2016; -ASCO; JUN 3-7, 2016; Chicago, USA. [Poster]

 

Winder, T; Posch, F; Asamer, E; Stotz, M; Siebenhuner, A; Schlick, K; Magnes, T; Samaras, P; Szkandera, J; Clavien, PA; Neureiter, D; Greil, R; Pestalozzi, BC; Stoeger, H; Gerger, A; Egle, A; Pichler, M An elevated fibrinogen/CRP ratio predicts a remarkable survival advantage in patients with metastatic pancreatic cancer
ANN ONCOL. 2016; 27: -41st Congress of the European-Society-for-Medical-Oncology (ESMO); OCT 07-11, 2016; Copenhagen, DENMARK. Doi: 10.1093/annonc/mdw371.77 [Poster]
Web of Science FullText FullText_MUG

 

Heu, C; Strenger, V; Szkandera, J; Friesenbichler, J; Urban, C; Leithner, A Is There An MTX Third Space Effect In Periprosthetic Seromas After Osteosarcoma Resection?
Abstracts of 18th EFORT, 3344;. 2015; -18th EFORT Congress 2015; MAY 27-29, 2015; Prague, CZECH REPUBLIC. [Poster]

 

Kainhofer, V; Szkandera, J; Smolle, M; Liegl-Atzwanger, B; Maurer-Ertl, W; Gerger, A; Leithner, A; How wide should an R0 resection be in soft tissue sarcoma surgery?
Scientific Posters of ISOLS 2015; 10695. 2015; -ISOLS & MSTS; OCT 6-10, 2015; Orlando, FLORIDA. [Poster]

 

Maderthaner, R; Liegl-Atzwanger, B; Leithner, A; Szkandera, J Case 2
5th Annual Meeting of the Austrian Musculo-Skeletal Oncology Society; DEC 7, 2015; Vienna, AUSTRIA. 2015. [Oral Communication]

 

Stotz, M; Herzog, SA; Pichler, M; Szkandera, J; Schaberl-Moser, R; Samonigg, H; Renner, W; Berghold, A; Gerger, A; Cancer stem cell gene variants and colon cancer prognosis.
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie; April 23-25, 2015; Salzburg. 2015. [Poster]

 

Szkandera, J Optimale Steuerung der Therapie bei GIST
2. Interdisziplinäres Fortbildung des CCC Graz, Subzentrum Sarkome ; OCT 22, 2015; Pörtschach am Wörthersee, AUSTRIA. 2015. [Oral Communication]

 

Szkandera, J Metastatic disease: Gold Standard of systemic therapy.
AMSOS; DEZ 7, 2015; Vienna, AUSTRIA. 2015. [Oral Communication]

 

Szkandera, J Optimale Steuerung der Therapie bei GIST
2. Interdisziplinäres Fortbildung des CCC Graz, Subzentrum Sarkome; OCT 22, 2015; Klagenfurt, AUSTRIA. 2015. [Oral Communication]

 

Szkandera, J Metastatic disease: Gold Standards of systemic therapy
5th Annual Meeting of the Austrian Musculo-Skeletal Oncology Society; DEZ 7, 2015; Vienna, AUSTRIA. 2015. [Oral Communication]

 

Friesenbichler, J; Maurer-Ertl, W; Sadoghi, P; Szkandera, J; Pirker-Frühauf, U; Weger, C; Leithner, A Serum metal ion concentrations following mega¬prosthetic knee replacement for tumour indications: Is there a matter of concern?
Abstract Book of the 10th CEOC, P-26. 2014; -10th Central European Orthopaedic Congress & Congress of the Croatian Orthopaedic and Traumatology Association; MAY 8-11, 2014; Split, CROATIA. [Poster]

 

Glehr, M; Friesenbichler, J; Bernhardt, GA; Windhager, R; Hofmann, G; Szkandera, J; Avian, A; Leithner, A Novel Biomarkers to Detect Infection in Orthopedic Revision Arthroplasty.
Abstractbook of EMSOS 2014, P10.01. 2014; 62--27th Annual Meeting of the European Musculo-Skeletal Oncology Society (EMSOS); May 22-23, 2014; Vienna, AUSTRIA. [Poster]

 

Heu, C; Strenger, V; Friesenbichler, J; Szkandera, J; Leithner, A Methotrexat Konzentrationen bei Osteosarkom Patienten in Dritträumen.
Abstractband des DKOU 2014. 2014; -DKOU 2014; OCT 28-31, 2014; Berlin, GERMANY. [Oral Communication]

 

Kainhofer, V; Szkandera, J; Liegl-Atzwanger, B; Maurer-Ertl, W; Gerger, A; Leithner, A Local recurrences after resection of soft tissue sarcomas: a multifactorial analysis.
Abstractbook of EMSOS 2014, 02.02. 2014; 9--27th Annual Meeting of the European Musculo-Skeletal Oncology Society (EMSOS); May 22-23, 2014; Vienna, AUSTRIA. [Oral Communication]

 

Kainhofer, V; Szkandera, J; Liegl-Atzwanger, B; Maurer-Ertl, W; Gerger, A; Leithner, A LOCAL RECURRENCES OF SOFT TISSUE SARCOMAS: R-CLASSIFICATION VERSUS UICC-CLASSIFICATION OF RESECTION MARGINS.
Abstracts of CTOS 2014 Annual Meeting, P 253. 2014; 293--CTOS 2014 Annual Meeting; OCT 15-18, 2014; Berlin, GERMANY. [Poster]

 

Schaffler, A; Andreou, D; Tunn, PU; Szkandera, J; Maurer-Ertl, W; Leithner, A Intra-abdominelle und retroperitoneale Metastasen bei 613 Patienten und Patientinnen mit Weichteilsarkom - eine 2-Zentren-Studie.
Abstractband des DKOU 2014. 2014; -DKOU 2014; OCT 28-31, 2014; Berlin, GERMANY. [Poster]

 

Stotz, M; Pichler, M; Bezan, A; Peinsith, H; Szkandera, J; Arminger, F; Schaberl-Moser, R; Samonigg, H; Stojakovic, T; Gerger, A The preoperative C-reactive protein (CRP) and fibrinogen level predicts clinical outcome in patients with stage III colon cancer
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie; April 10-12, 2014; Innsbruck. 2014. [Poster]

 

Stotz, M; Szkandera, J; Stojakovic, T; Samonigg, H; Kornprat, P; Ress, AL; Seggewies, F; Gerger, A; Pichler, M Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie; April 10-12, 2014; Innsbruck. 2014. [Poster]

 

Stotz, M; Szkandera, J; Stojakovic, T; Samonigg, H; Kornprat, P; Ress, AL; Seggewies, F; Gerger, A; Pichler, M The lymphocyte to monocyte ratio in peripheral blood represents a novel prognostic marker in patients with pancreatic cancer.
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie; April 10-12, 2014; Innsbruck. 2014. [Poster]

 

Szkandera, J; Gerger, A; Liegl-Atzwanger, B; Absenger, G; Stotz, M; Friesenbichler, J; Stojakovic, T; Eberhard, K; Leithner, A; Pichler, M The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas.
Abstractbook of EMSOS 2014, P02.04. 2014; 44--27th Annual Meeting of the European Musculo-Skeletal Oncology Society (EMSOS); May 22-23, 2014; Vienna, AUSTRIA. [Poster]

 

Szkandera, J; Gerger, A; Liegl-Atzwanger, B; Absenger, G; Stotz, M; Friesenbichler, J; Trajanoski, S; Stojakovic, T; Eberhard, K; Leithner, A; Pichler, M The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas
Jahrestagung der DGHO, ÖGHO, SGMO und SGH ; OKT 10-14, 2014; Hamburg, Deutschland. 2014. [Oral Communication]

 

Friesenbichler, J; Maurer-Ertl, W; Sadoghi, P; Szkandera, J; Pirker-Fruehauf, U; Weger, C; Leithner, A Serum metal ion concentrations following total knee arthroplasty using megaprostheses for tumour indications: Is there a matter of concern?
Abstracts of 26th EMSOS; P15:103. 2013; -26th EMSOS; MAY 29-31, 2013; Gothenburg, SWEDEN. [Poster]

 

Friesenbichler, J; Maurer-Ertl, W; Sadoghi, P; Szkandera, J; Pirker-Frühauf, U; Weger, C; Leithner, A Serum Metallionenkonzentration nach Kniegelenksersatz mit Megaprothesen: Ein Vergleich mehrerer Prothesengruppen.
DKOU 2013, P019-839. 2013; -DKOU 2013; OKT 22-25, 2013; Berlin, GERMANY. [Poster]

 

Friesenbichler, J; Maurer-Ertl, W; Sadoghi, P; Szkandera, J; Pirker-Frühauf, U; Weger, C; Leithner, A Serum Metallionenkonzentration nach Kniegelenksersatz mit Megaprosthesen: Ein Vergleich mehrerer Prothesentypen.
E-Poster. 2013; -31. Jahrestagung der ÖGO; SEP 12-14, 2013; Krems, AUSTRIA. [Poster]

 

Friesenbichler, J; Maurer-Ertl, W; Szkandera, J; Pirker-Frühauf, U; Weger, C; Leithner, A Serum Metallionenkonzentrationnach Kniegelenksersatz mit Megaprosthesen bei pädiatrischen Patienten: Ein Vergleich mehrerer Prothesengruppen.
Abstractband AMSOS Wien. 2013; -AMSOS Wien; APR 26-27, 2013; Vienna, AUSTRIA. [Poster]

 

Heu, C; Strenger, V; Szkandera, J; Friesenbichler, J; Prattes, G; Urban, EC; Leithner, A Do periprosthetic seromas contribute to a third space effect after high dose Methotrexate?
Abstracts of 26th EMSOS; O6:109. 2013; -26th EMSOS; MAY 29-31, 2013; Gothenburg, SWEDEN. [Oral Communication]

 

Heu, C; Strenger, V; Szkandera, J; Friesenbichler, J; Urban, C; Leithner, A DO PERIPROSTHETIC SEROMAS CONTRIBUTE TO A THIRD SPACE EFFECT AFTER HIGH DOSE.
Abstracts of the 18th Annual Meeting CTOS, P 35. 2013; -Connective Tissue Oncology Society 18th Annual Meeting; OCT 30 - NOV 2, 2013; New York, USA. [Poster]

 

Hofmann, G; Langsenlehner, T; Moazedi-Fuerst, F; Kielhauser, S; Gerger, A; Absenger, G; Glehr, M; Szkandera, J; Samonigg, H; Krippl, P; Renner, W Association of a common single nucleotide polymorphism in the TRAIL-R1 gene with relapse-free survival in rectal cancer patients.
Annals of Oncology. 2013; 24, Suppl. 4: iv51-iv52.-ESMO 15th World Congress on Gastrointestinal Cancer; JULY, 3-6, 2013; Barcelona, SPAIN. (ISBN: 0923-7534 ) [Poster]

 

Leithner, A; Szkandera, J; Ploner, F; Maurer-Ertl, W; Liegl-Atzwanger, B Neue Therapieansätze in der Therapie der aggressiven Fibromatose.
Abstractband AMSOS Wien. 2013; -AMSOS Wien; APR 26-27, 2013; Vienna, AUSTRIA. [Oral Communication]

 

Schaffler, A; Andreou, D; Tunn, PU; Szkandera, J; Maurer-Ertl, W; Leithner, A INTRA-ABDOMINAL AND RETROPERITONEAL METASTASES IN PATIENTS WITH EXTRA-ABDOMINAL STS: A TWO-CENTER RETROSPECTIVE STUDY OF 613 PATIENTS.
Abstracts of the 18th Annual Meeting CTOS, P 209. 2013; -Connective Tissue Oncology Society 18th Annual Meeting; OCT 30 - NOV 2, 2013; New York, USA. [Poster]

 

Schaffler, A; Andreou, D; Tunn, PU; Szkandera, J; Zacherl, M; Leithner, A Intra-abdominal and retroperitoneal metastases in patients with soft tissue sarcomas - a two-center study.
Abstracts of 26th EMSOS; PSR:103. 2013; -26th EMSOS; MAY 29-31, 2013; Gothenburg, SWEDEN. [Oral Communication]

 

Schaffler, A; Andreou, D; Tunn, PU; Szkandera, J; Zacherl, M; Leithner, A Intra-abdominal and retroperitoneal metastases in patients with soft tissue sarcomas - a two-center study.
Abstracts of 26th EMSOS; P6:116. 2013; -26th EMSOS; MAY 29-31, 2013; Gothenburg, SWEDEN. [Poster]

 

Schaffler, A; Szkandera, J; Dimosthenis, A; Tunn, PU; Leithner, A Intra-abdominelle und retroperitoneale Metastasen bei 613 Patienten mit Weichteilsarkomen.
4. Jahrestagung der Österreichischen Gesellschaft für Tumororthopädie; APR 26-27, 2013; Vienna, AUSTRIA. 2013. [Oral Communication]

 

Szkandera, J; Absenger, G; Liegl-Atzwanger, B; Pichler, M; Stotz, M; Zacherl, M; Renner, W; Leithner, A; Gerger, A Common gene variants in RAD51, XRCC2 and XPD are not associated with clinical outcome in soft-tissue sarcoma patients.
Abstracts of 26th EMSOS; P4:102. 2013; -26th EMSOS; MAY 29-31, 2013; Gothenburg, SWEDEN. [Poster]

 

Szkandera, J; Absenger, G; Liegl-Atzwanger, B; Pichler, M; Zacherl, M; Samonigg, H; Stojakovic, T; Gerger, A; Leithner, A Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients.
Abstracts of 26th EMSOS; PSR:110. 2013; -26th EMSOS; MAY 29-31, 2013; Gothenburg, SWEDEN. [Oral Communication]

 

Szkandera, J; Absenger, G; Liegl-Atzwanger, B; Pichler, M; Zacherl, M; Samonigg; H; Stojakovic, T; Gerger, A; Leithner, A Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients.
Abstracts of 26th EMSOS; P6:101. 2013; -26th EMSOS; MAY 29-31, 2013; Gothenburg, SWEDEN. [Poster]

 

Szkandera, J; Absenger, G; Weissmueller, M; Pichler, M; Stotz, M; Lax, S; Leitner, G; Asslaber, M; Renner, W; Gerger, A Prediction of clinical outcome in stage II and III colon cancer by a common gene variant in AXIN2
Journal of Clinical Oncology . 2013; 30(34):-2013 Gastrointestinal Cancers Symposium; Jan 24-26, 2013; San Francisco, USA. [Poster]

 

Szkandera, J; Absenger, G; Weissmueller, M; Stotz, M; Pichler, M; Lax, S; Leitner, G; Asslaber, M; Renner, W; Gerger, A A common gene variant in AXIN2 predicts clinical outcome in stage II and III colon cancer
387 (A55). 2013; -ASCO GI; JAN 24-26, 2013; San Francisco, USA. [Poster]

 

Szkandera, J; Gerger, A; Liegl-Atzwanger, B; Absenger, G; Stotz, M; Samonigg, H; Maurer-Ertl, W; Stojakovic, T; Ploner, F; Leithner, A; Pichler, M VALIDATION OF THE PROGNOSTIC RELEVANCE OF PLASMA C-REACTIVE PROTEIN LEVELS IN SOFT TISSUE SARCOMA.
Abstracts of the 18th Annual Meeting CTOS, P 94. 2013; -Connective Tissue Oncology Society 18th Annual Meeting; OCT 30 - NOV 2, 2013; New York, USA. [Poster]

 

Szkandera, J; Pichler, M; Liegl-Atzwanger, B; Absenger, G; Stotz, M; Ploner, F; Stojakovic, T; Samonigg, H; Leithner, A; Gerger, A THE ELEVATED PRE-OPERATIVE PLASMA FIBRINOGEN LEVEL IS AN INDEPENDENT NEGATIVE PROGNOSTIC FACTOR FOR CANCER-SPECIFIC; METASTASIS-FREE AND OVERALL SURVIVAL IN SOFT-TISSUE SARCOMA PATIENTS.
Abstracts of the 18th Annual Meeting CTOS, P 93. 2013; -Connective Tissue Oncology Society 18th Annual Meeting; OCT 30 - NOV 2, 2013; New York, USA. [Poster]

 

Winder, T; Szkandera, J; Absenger, G; Weismüller, M; Pichler, M; Stotz, M; Lax, S; Leitner, G; Asslaber, M; Renner, W; Samonigg, H; Gerger, A A functional germline variant in Hedgheog pathway gene GLI1 identifies patients at high risk of tumor recurrence in stage II and III colon cancer
http://worldgicancer.com/WCGI/WGIC2013/. 2013; -World Congress on Gastrointestinal Cancer; July 3-6, 2013; Barcelona, Spain. [Oral Communication]

 

Absenger, G; Szkandera, J; Weissmüller, M; Postlmayr, U; Pichler, M; Loibner, H; Samonigg, H; Gerger, A The preoperative neutrophil to lymphocyte ratio predicts disease-free survival and overall survival in patients with stage II and III colon cancer
Onkologie - International Journal for Cancer Research and Treatment. 2012; 35(6):55-56.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaft für Hämatologie und Onkologie; OCT 19-23, 2012; Stuttgard, Germany. [Poster]

 

Absenger, G; Szkandera, J; Weissmuller, M; Postlmayr, U; Pichler, M; Loibner, H; Samonigg, HS; Gerger, A; The preoperative neutrophil to lymphocyte ratio predicts disease-free survival and overall survival in patients with stage II and III colon cancer.
ONKOLOGIE. ONKOLOGIE35: 55-56. BASEL: KARGER; [Poster]
Web of Science

 

Friesenbichler, J; Maurer-Ertl, W; Sadoghi, P; Szkandera, J; Weger, C; Pirker-Fruehauf, U; Leithner, A Serum metal ion concentrations in paediatric patients following total knee arthroplasty using megaprostheses: is there a matter of concern?
Abstractbook 5th RLHOTS. 2012; -Fifth Annual Meeting of the Rozal London Hospital Orthoapedic & Trauma Society; JUN 29, 2012; London, UK. [Poster]

 

Friesenbichler, J; Maurer-Ertl, W; Szkandera, J; Sadoghi, P; Weger, C; Pirker-Frühauf, U; Leithner, A Serum metal ion levels in pediatric patients following knee reconstruction using megaprostheses.
Abstracts of the 25th Annual Meeting of the European MusculoSkeletal Oncology Society; 029. 2012; 160--25th Annual Meeting of the European MusculoSkeletal Oncology Society; MAY 15-16, 2012; Bologna, ITALY. [Poster]

 

Friesenbichler, J; Maurer-Ertl, W; Szkandera, J; Sadoghi, P; Weger, C; Pirker-Frühauf, U; Leithner, A Serum-Metall-Ionen Konzentrationen nach Kniegelenksrekonstruktion mit achsgeführten Megaprothesen bei pädiatrischen Patienten.
Abstractbook der 3. Jahrestagung der Österreichischen Gesellschaft für Tumororthopädie. 2012; 27--3. Jahrestagung der Österreichischen Gesellschaft für Tumororthopädie; APR 20-21, 2012; Graz, AUSTRIA. [Oral Communication]

 

Friesenbichler, J; Maurer-Ertl, W; Szkandera, J; Sadoghi, P; Weger, C; Pirker-Frühauf, U; Leithner, A SERUM METAL ION LEVELS IN PEDIATRIC PATIENTS FOLLOWING KNEE RECONSTRUCTION USING MEGAPROSTHESES.
Proceedings of the 33rd SICOT; 32360. 2012; -Combined 33rd SICOT & 17th PAOA; NOV 28-30, 2012; Dubai, UNITED ARAB EMIRATES. [Poster]

 

Hofmann, G; Langsenlehner, T; Moazedi-Fuerst, F; Gerger, A; Kielhauser, S; Absenger, G; Szkandera, J; Samonigg, H; Krippl, P; Renner, W; COMMON VEGF GENE POLYMORPHISMS ARE NOT ASSOCIATED WITH RELAPSE-FREE SURVIVAL IN COLORECTAL CANCER PATIENTS.
ANN ONCOL. 2012; 23: 86-87.-14th World Congress on Gastrointestinal Cancer of the European-Society-for-Medical-Oncology (ESMO); JUN 27-30, 2012; Barcelona, SPAIN. [Poster]
Web of Science

 

Hofmann, G; Langsenlehner, T; Moazedi-Fuerst, F; Gerger, A; Kielhauser, S; Thurner, E-M; Absenger, G; Szkandera, J; Samonigg, H; Glehr, M; Krippl, P; Renner, W Genetic variants of UGT1A4 and their impact on relapse-free survival in Tamoxifen treated breast cancer patients.
Onkologie. 2012; 35(S 6):64-64.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 19-23, 2012; Stuttgart, GERMANY. [Poster]
Web of Science

 

Marx-Neuhold, EA; Zulus, B; Absenger, G; Szkandera, J; Schippinger, W; Gerger, A; Renner, W A common polymorphism in the promoter of the erythropoietin gene is associated with delayed onset of peripheral arterial disease.
Drug Metabolism and Drug Interactions. 2012; 27(3):39-39.-6th Santorini Conference Biologie Prospective; SEP 30-OKT 2, 2012; Thira, GREECE. [Poster]

 

Szkandera, J; Absenger, G; Dandachi, N; Regitnig, P; Lax, S; Stotz, M; Winder, T; Samonigg, H; Renner, W; Gerger, A Analysis of functional germline polymorphisms for prediction of response to anthracycline-based neoadjuvant chemotherapy in breast cancer
WIEN KLIN WOCHENSCHR. 2012; 124(15-16):575-575. [Poster]
Web of Science

 

Szkandera, J; Absenger, G; Stotz, M; Weissmuller, M; Winder, T; Langsenlehner, T; Samonigg, H; Renner, W; Schippinger, W; Gerger, A The functional polymorphism of erythropoietin gene rs1617640 G > T is not associated with susceptibility and clinical outcome of early-stage breast cancer
WIEN KLIN WOCHENSCHR. 2012; 124(15-16):575-575. [Poster]
Web of Science

 

Szkandera, J; Winder, T; Absenger, G; Stotz, M; Weissmuller, M; Langsenlehner, T; Hofmann, G; Samonigg, H; Renner, W; Gerger, A; A COMMON GENE VARIANT IN PLS3 PREDICTS COLON CANCER RECURRENCE IN WOMEN.
ANN ONCOL. 2012; 23: 83-83.-14th World Congress on Gastrointestinal Cancer of the European-Society-for-Medical-Oncology (ESMO); JUN 27-30, 2012; Barcelona, SPAIN. [Poster]
Web of Science

 

Szkandera, J; Zulus, B; Absenger, G; Stotz, M; Weissmueller, M; Winder, T; Langsenlehner, T; Samonigg, H; Renner, W; Schippinger, W; Gerger, A The functional rs1617640 polymorphism in the promoter of the erythropoietin gene is not associated with susceptibility and outcome of early-stage breast cancer.
Drug Metabolism and Drug Interactions. 2012; 27(3):22-22.-6th Santorini Conference Biologie Prospective.; SEP 30-OKT 2, 2012; Thira, GREECE. [Poster]

 

Thurner, EM; Krenn-Pilko, S; Renner, W; Szkandera, J; Gerger, A; Langsenlehner, U; Kapp, KS; Langsenlehner, T; Role of Polymorphisms in the ERCC2 Gene in the Development of Severe Side Effects After Radiotherapy of Prostate Cancer Patients.
EUR J CANCER. EUROPEAN JOURNAL OF CANCER48: S271-S271. OXFORD: ELSEVIER SCI LTD; ( Presented at: 22nd Biennial Congress of the European-Association-for-Cancer-Research, Barcelona, SPAIN, JUL 07-10, 2012) Doi: 10.1016/S0959-8049(12)71727-6 [Poster]
Web of Science FullText FullText_MUG

 

Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Szkandera, J; Absenger, G; Samonigg, H; Krippl, P; Renner, W A COMMON HEREDITARY SINGLE NUCLEOTIDE POLYMORPHISM IN THE IN THE GENE OF DEATH RECEPTOR 4 (TNFRSF10A) AND ITS IMPACT ON OVERALL SURVIVAL IN RECTAL CANCER PATIENTS
ANN ONCOL. . 2011; 22: v129-v129.-ESMO 13th World Congress on Gastrointestinal Cancer; JUN 22-25, 2011; Barcelona, SPAIN. [Poster]
Web of Science

 

Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Szkandera, J; Absenger, G; Samonigg, H; Krippl, P; Renner, W Common single nucleotide polymorphisms in the genes of integrin alpha-2 and beta-3 subunits are not associated with overall survival in rectal cancer patients
ONKOLOGIE. 2011; 34: 245-246.-Gemeinsame Jahrestagung 2011 der DGHO, ÖGHO, SGMO und SGH+SSH; SEP 30-OCT 4, 2011; Basel, SWITZERLAND. [Poster]
Web of Science

 

Leithner, A; Szkandera, J; Zacherl, M; Wibmer, C; Lohberger, B; Glehr, M; Kretschmer, N; Beham, A; Maurer-Ertl, W; Renner, B; Liegl, B Weichteilsarkome.
8. Wissenschaftliche Sitzung der Gesellschaft der Ärzte in der Steiermark; APR 7, 2011; Graz, AUSTRIA. 2011. [Oral Communication]

 

Hofmann, G; Langsenlehner, T; Fuerst, F; Szkandera, J; Gerger, A; Langsenlehner, U; Krippl, P; Renner, W Association of a single nucleotide polymorphism in the gene of TNFRSF10A (TRAILR-1) with relapse-free survival in colorectal cancer.
Onkologie2010; 33(S 6):173-173.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 1-5, 2010; Berlin, GERMANY. (ISBN: 0378-584X ) [Poster]
Web of Science

 

Knechtel, G; Szkandera, J; Stotz, M; Hofmann, G; Langsenlehner, U; Krippl, P; Samonigg, H; Renner, W; Dehchamani, D; Gerger, A Single nucleotide polymorphisms in the hypoxia-inducible factor 1 gene and colorectal cancer risk
Onkologie-International Journal for Cancer Research and Treatment2010; 33(S6):225-226.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OKT 1-5, 2010; Berlin, GERMANY. (ISBN: 978-3-8055-9633-6 ) [Oral Communication]
Web of Science

 

Knechtel, G; 1, Szkandera, J; Stotz, M; Hofmann, G; Langsenlehner, U; Krippl, P; Samonigg, H; Renner, W; Langner, C; Dehchamani, D; Gerger, A; Single nucleotide polymorphisms in the hypoxia-inducible factor 1 gene and colorectal cancer risk
MEMO Suppl 01/10; 2010; 16-17.-Frühjahrstagung 2010 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 8-10, 2010; Bregenz, AUSTRIA. [Poster]

 

Rühlinger, D; Szkandera, J; Pichler, M; Eisner, F; Stöger, H; Bauernhofer, T; Sorafinib as forth-line treatment in a patient with metastatic gastrointestinal stromal tumour: a case report.
MEMO Suppl 01/10; 2010; 20-20.-Frühjahrstagung 2010 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 8-10, 2010; Bregenz, AUSTRIA. [Poster]

 

Szkandera, J Stable disease of 16 months duration achieved with Sunitinib in a patient with KIT Exon 9 jejunal GIST resistant to Imatinib therapy
ArcheoloGIST Summit ; 14.-15.1.2010; Athens, Greece. 2010. [Poster]

 

Szkandera, J; Knechtel, G; Stotz, M; Hofmann, G; Langsenlehner, U; Krippl, P; Langsenlehner, T; Dehchamani, D; Samonigg, H; Renner, W; Gerger, A Association of Hypoxia Inducible Factor 1-alpha Gene Polymorphisms and Colorectal Cancer Prognosis.
Onkologie-International Journal for Cancer Research and Treatment2010; 33(S6):226-226.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OKT 1-5, 2010; Berlin, GERMANY. (ISBN: 978-3-8055-9633-6 ) [Oral Communication]
Web of Science

 

Szkandera, J; Knechtel, G; Stotz, M; Hofmann, G; Langsenlehner, U; Krippl, P; Langsenlehner, T; Dehchamani, D; Samonigg, H; Renner, W; Gerger, A Assiciation of hypoxia inducible factor 1-alpha gene polymorphisms and colorectal cancer prognosis.
MEMO Suppl 01/10; 2010; 16-16.-Frühjahrstagung 2010 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 8-10, 2010; Bregenz, AUSTRIA. [Poster]

 

Szkandera, J; Ploner, F; Bauernhofer, T; Kasparek, AK; Payer, F; Balic, M; Knechtel, G; Gerger, A; Galle; Samonigg, H; Hofmann, g; Paraneoplastic limbic encephalitis in a patient with extragonadal chorioncarcinoma - the significance of onconeural antibodies: a case report
MEMO Suppl 01/10; 2010; 20-21.-Frühjahrstagung 2010 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 8-10; Bregenz, AUSTRIA . [Poster]

 

Gerger, A; Renner, W; Langsenlehner, T; Hofmann, G; Knechtel, G; Szkandera, J; Samonigg, H; Krippl, P; Langselnlehner, U Association of Interleukin-10 gene variation wit breast cancer prognosis
Frühjahrstagung 2009 der Österreichischen Gesellschaft für Hämatologie und Onkologie; April 14-16, 2009; Salzburg. 2009. [Poster]

 

Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Knechtel, G; Szkandera, J; Krippl, P; Renner, W Colorectal cancer survival and its association to a common hereditary polymorphism in the gene of Death Receptor 4 (TNFRSF10A)
MEMO Suppl 02/09; 2009; 2: 21-21.-Frühjahrstagung 2009 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APRIL 16-18, 2009; Salzburg, AUSTRIA. [Poster]

 

Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Knechtel, G; Szkandera, J; Krippl, P; Renner, W The 683A>C polymorphism in the ligand binding domain of TRAILR-1 (TNFRSF10A) is not associated with colorectal cancer survival.
Annals of Oncology2009; 20(S 7):31-31.-11th World Congress on Gastrointestinal Cancer ; JUNE 24-27, 2009; Barcelona, SPAIN. [Poster]
Web of Science

 

Knechtel, G; Gerger, A; Renner, W; Langsenlehner, T; Hofmann, G; Szkandera, J; Samonigg, H; Krippl, P; Langsenlehner, U Analysis of common germline polymorphisms to predict metastasis in node-positive breast cancer
MEMO Suppl 02/09; 2009; 2: 20-21.-Frühjahrstagung 2009 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APRIL 16-18, 2009; Salzburg, AUSTRIA. [Oral Communication]

 

Knechtel, G; Stoeger, H; Szkandera, J; Dorr, K; Beham, A; Samonigg, H Desmoid tumor treated with polychemotherapy followed by Imatinib A case report and a review of literature
MEMO Suppl 02/09; 2009; 2: 20-20.-Frühjahrstagung 2009 der Österreichischen Gesellschaft für Hämatologie und Onkologie ; APRIL 14-16, 2009; Salzburg, AUSTRIA. [Poster]

 

Szkandera, J; Balic, M; Rapp, N; Strutz, J; Cote, RJ; Samonigg, H Neue Methoden zum Nachweis und Charakterisierung vermeintlicher disseminierter Brustkrebsstammzellen.
MEMO Suppl 02/09; 2009; 2: 1-1.-Frühjahrstagung 2009 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 16-18, 2009; Salzburg, AUSTRIA. [Oral Communication]

 

Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Samonigg, H; Szkandera, J; Krippl, P; Renner, W Colorectal cancer survival and its association to a hereditary polymorphism in the promoter-gene of FAS
MEMO2008; Volume 1, Suppl 1: 4-5.-Frühjahrstagung 2008 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 10-12, 2008; Innsbruck, AUSTRIA. [Oral Communication]

 

Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Szkandera, J; Samonigg, H; Clar, H; Krippl, P; Renner, W Association of a common -1377 G>A polymorphism in the gene of FAS (TNFRSF6) with metastasis-free survival in rectal cancer.
Onkologie 2008; 31 (suppl 4): 104-104.-Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 10-14, 2008; Vienna, AUSTRIA. [Poster]

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum